<SEC-DOCUMENT>0001104659-17-075519-index.html : 20171229
<SEC-HEADER>0001104659-17-075519.hdr.sgml : 20171229
<ACCEPTANCE-DATETIME>20171229073032
ACCESSION NUMBER:		0001104659-17-075519
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		9
CONFORMED PERIOD OF REPORT:	20171229
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171229
DATE AS OF CHANGE:		20171229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celldex Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000744218
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				133191702
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15006
		FILM NUMBER:		171279772

	BUSINESS ADDRESS:	
		STREET 1:		53 FRONTAGE ROAD
		STREET 2:		SUITE 220
		CITY:			HAMPTON
		STATE:			NJ
		ZIP:			08827
		BUSINESS PHONE:		908-200-7500

	MAIL ADDRESS:	
		STREET 1:		53 FRONTAGE ROAD
		STREET 2:		SUITE 220
		CITY:			HAMPTON
		STATE:			NJ
		ZIP:			08827

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AVANT IMMUNOTHERAPEUTICS INC
		DATE OF NAME CHANGE:	19980828

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	T CELL SCIENCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a17-28883_18k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: a17-28883_18k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>a17-28883_1ex10d1.htm <DESCRIPTION>EX-10.1 <TEXT> Document 2 - file: a17-28883_1ex10d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>3 <FILENAME>a17-28883_1ex10d2.htm <DESCRIPTION>EX-10.2 <TEXT> Document 3 - file: a17-28883_1ex10d2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.3 <SEQUENCE>4 <FILENAME>a17-28883_1ex10d3.htm <DESCRIPTION>EX-10.3 <TEXT> Document 4 - file: a17-28883_1ex10d3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.4 <SEQUENCE>5 <FILENAME>a17-28883_1ex10d4.htm <DESCRIPTION>EX-10.4 <TEXT> Document 5 - file: a17-28883_1ex10d4.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.5 <SEQUENCE>6 <FILENAME>a17-28883_1ex10d5.htm <DESCRIPTION>EX-10.5 <TEXT> Document 6 - file: a17-28883_1ex10d5.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.6 <SEQUENCE>7 <FILENAME>a17-28883_1ex10d6.htm <DESCRIPTION>EX-10.6 <TEXT> Document 7 - file: a17-28883_1ex10d6.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.7 <SEQUENCE>8 <FILENAME>a17-28883_1ex10d7.htm <DESCRIPTION>EX-10.7 <TEXT> Document 8 - file: a17-28883_1ex10d7.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.8 <SEQUENCE>9 <FILENAME>a17-28883_1ex10d8.htm <DESCRIPTION>EX-10.8 <TEXT> Document 9 - file: a17-28883_1ex10d8.htm
</DOCUMENT> </SEC-DOCUMENT>